# FDA recall D-0862-2017

> **Hospira Inc.** · Class I · drug recall initiated 2017-04-21.

## Product

Infant 25% DEXTROSE Injection, USP, 2.5 g (250 mg/mL), 10 mL Unit of Use Single-dose Syringe per carton, Rx only, Hospira Inc., Lake Forest, IL 60045, NDC 0409-1775-10

## Reason for recall

Presence of Particulate Matter: human hair found within an internal sample syringe.

## Distribution

Nationwide in the USA and Puerto Rico

## Key facts

- **Recall number:** D-0862-2017
- **Recalling firm:** Hospira Inc.
- **Classification:** Class I
- **Product type:** drug
- **Status:** Ongoing
- **Initiation date:** 2017-04-21
- **Report date:** 2017-05-31

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Lake Forest, IL, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0862-2017

## Citation

> AI Analytics. FDA recall D-0862-2017. Retrieved 2026-05-27 from https://api.ai-analytics.org/recall/D-0862-2017. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*